Infant botulism: Two recent cases and literature review

Journal of Child Neurology

Volumn 23, Issue 11, 2008, Pages 1336-1346

  Domingo, Rose M ^a   Haller, Jerome S ^a   Gruenthal, Michael ^a  

^a ALBANY MEDICAL CENTER   (United States)

Author keywords

Botulism immune globulin; Epidemiology; Infant botulism

Indexed keywords

BOTULINUM TOXIN B; CEFAZOLIN; CEFTRIAXONE; DEXAMETHASONE; HUMAN IMMUNOGLOBULIN; STEROID;

ABSENCE OF SIDE EFFECTS; BOTULISM; BREAST FEEDING; CASE REPORT; CLOSTRIDIUM BOTULINUM; CONSTIPATION; DYSPHAGIA; FECES ANALYSIS; FEMALE; FOLLOW UP; FOOD REGURGITATION; HOSPITAL READMISSION; HUMAN; ILEUS; INFANT; IRRITABILITY; METABOLIC ACIDOSIS; MUSCLE HYPOTONIA; PRIORITY JOURNAL; PTOSIS; REVIEW; STRIDOR; SUBGLOTTIC STENOSIS; TACHYCARDIA; THRUSH; TRACHEOSTOMY; UNITED STATES; URINE VOLUME;

BOTULISM; FEMALE; HUMANS; INFANT;

EID: 54549098280     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/0883073808318200     Document Type: Review

References (47)

1. Fox CK, Keet CA, Strober JB Recent advances in infant botulism. Pediatr Neurol. 2005; 32 (3): 149-154.
2. Sobel J. Botulism. Clin Infect Dis. 2005; 41 (8): 1167-1173.
3. Partikian A., Mitchell WG Iatrogenic botulism in a child with spastic quadriparesis. J Child Neurol. 2007; 22 (10): 1235-1237.
4. Chertow DS, Tan ET, Maslanka SE, et al. Botulism in 4 adults following cosmetic injections with an unlicensed, highly concentrated botulinum preparation. JAMA. 2006; 296 (20): 2476-2479.
5. Souayah N., Karim H., Kamin SS, et al. Severe botulism after focal injection of botulinum toxin. Neurology. 2006; 67 (10): 1855-1856.
6. Pickett J., Berg B., Chaplin E., Brunstetter-Shafer MA Syndrome of botulism in infancy: Clinical and electrophysiologic study. N Engl J Med. 1976; 295 (14): 770-772.
7. Centers for Disease Control and Prevention. Botulism in the United States, 1899-1996. Handbook for Epidemiologists, Clinicians, and Laboratory Workers. Atlanta, GA: Centers for Disease Control and Prevention; 1998.
8. Centers for Disease Control and Prevention. Surveillance for Botulism, Summary of 2005 Data. Atlanta, GA: Centers for Disease Control and Prevention; 2007.
9. Gimenez DF, Gimenez JA Serological subtypes of botulinal neurotoxins. In: Das Gupta BR, ed. Botulism and Tetanus Neurotoxins: Neurotransmission and Biomedical Aspects. New York, NY: Plenum Press; 1993: 421-431.
10. Long SS Botulism in infancy. Pediatr Infect Dis. 1984; 3 (3): 266-271.
11. Shapiro RL, Hatheway C., Swerdlow DL Botulism in the United States: A clinical and epidemiologic review. Ann Intern Med. 1998; 129 (3): 221-228.
12. Barash JR, Arnon SS Dual toxin-producing strain of Clostridium botulinum type Bf isolated from a California patient with infant botulism. J Clin Microbiol. 2004; 42 (4): 1713-1715.
13. Barash JR, Tang TW, Arnon SS First case of infant botulism caused by Clostridium baratii type F in California. J Clin Microbiol. 2005; 43 (8): 4280-4282.
14. Keet CA, Fox CK, Margeta M., et al. Infant botulism, type F, presenting at 54 hours of life. Pediatr Neurol. 2005; 32 (3): 193-196.
15. Glauser TA, Maguire HC, Sladky JT Relapse of infant botulism. Ann Neurol. 1990; 28 (2): 187-189.
16. Thompson JA, Glasgow LA, Warpinski JR, Olson C. Infant botulism: clinical spectrum and epidemiology. Pediatrics. 1980; 66 (6): 936-942.
17. Francisco AM, Arnon SS Clinical mimics of infant botulism. Pediatrics. 2007; 119 (4): 826-828.
18. Mitchell WG, Tseng-Ong L. Catastrophic presentation of infant botulism may obscure or delay diagnosis. Pediatrics. 2005; 116 (3): E436-438.
19. Long SS Infant botulism. Pediatr Infect Dis J. 2001; 20 (7): 707-709.
20. Li LY, Kelkar P., Exconde RE, et al. Adult-onset "infant" botulism: An unusual cause of weakness in the intensive care unit. Neurology. 1999; 53 (4): 891.
21. Midura TF Update: Infant botulism. Clin Microbiol Rev. 1996; 9 (2): 119-125.
22. Long SS, Gajewski JL, Brown LW, Gilligan PH Clinical, laboratory, and environmental features of infant botulism in Southeastern Pennsylvania. Pediatrics. 1985; 75 (5): 935-941.
23. Schreiner MS, Field E., Ruddy R. Infant botulism: A review of 12 years' experience at the Children's Hospital of Philadelphia. Pediatrics. 1991; 87 (2):159-165.
24. Morris JG Jr, Snyder JD, Wilson R., Feldman RA Infant botulism in the United States: An epidemiologic study of cases occurring outside of California. Am J Public Health. 1983; 73 (12): 1385-1388.
25. Spika JS, Shaffer N., Hargrett-Bean N., et al. Risk factors for infant botulism in the United States. Am J Dis Child. 1989; 143 (7): 828-832.
26. Arnon SS Infant botulism: Anticipating the second decade. J Infect Dis. 1986; 154 (2): 201-206.
27. Smith LD Clostridium botulinum: Characteristics and occurrence. Rev Infect Dis. 1979; 1 (4): 637-641.
28. Long SS Epidemiologic study of infant botulism in Pennsylvania: Report of the infant botulism study group. Pediatrics. 1985; 75 (5): 928-934.
29. Centers for Disease Control and Prevention. Infant botulism- New York City, 2001-2002. MMWR Morb Mortal Wkly Rep. 2003; 52 (2): 21-24.
30. Arnon SS, Damus K., Chin J. Infant botulism: Epidemiology and relation to sudden infant death syndrome. Epidemiol Rev. 1981; 3: 45-66.
31. Arnon SS, Midura TF, Damus K., et al. Honey and other environmental risk factors for infant botulism. J Pediatr. 1979;94 (2): 331-336.
32. American Academy of Pediatrics. Clostridial infections. In: Peter G, ed. 1994 Red Book, Report of the Committee on Infectious Diseases. 23 rd ed. Elk Grove Village, IL: American Academy of Pediatrics; 1994: 160-166.
33. American Academy of Pediatrics. Clostridial infections. In: Peter G, ed. 1997 Red Book, Report of the Committee on Infectious Diseases. 24 th ed. Elk Grove Village, IL: American Academy of Pediatrics; 1997: 174-181.
34. Thompson JA, Filloux FM, Van Orman CB, et al. Infant botulism in the age of botulism immune globulin. Neurology. 2005; 64 (12): 2029-2032.
35. Cherington M. Electrophysiologic methods as an aid in diagnosis of botulism: A review. Muscle Nerve. 1982; 5 (9S): S28-29.
36. Paton WDM, Waud DR The margin of safety of neuromuscular transmission. J Physiol. 1967; 191: 595.
37. Arnon SS, Schechter R., Maslanka SE, et al. Human botulism immune globulin for the treatment of infant botulism. N Engl J Med. 2006; 354 (5): 462-471.
38. Long SS Infant botulism and treatment with BIG-IV (BabyBIG). Pediatr Infect Dis J. 2007; 26 (3): 261-262.
39. Cherington M. Botulism: Update and review. Semin Neurol. 2004; 24 (2):155-163.
40. Underwood K., Rubin S., Deakers T., Newth C. Infant botulism: A 30-year experience spanning the introduction of botulism immune globulin intravenous in the intensive care unit at Children's Hospital Los Angeles. Pediatrics. 2007; 120 (6): E1380-1385.
41. Tseng-Ong L., Mitchell WG Infant botulism: 20 years' experience at a single institution. J Child Neurol. 2007; 22 (12): 1333-1337.
42. Anderson TD, Shah UK, Schreiner MS, Jacobs IN Airway complications of infant botulism: Ten-year experience with 60 cases. Otolaryngol Head Neck Surg. 2002;126 (3): 234-239.
43. Kurland G., Seltzer J. Antidiuretic hormone excess in infant botulism. Am J Dis Child. 1987; 141 (11): 1227-1229.
44. Schechter R., Peterson B., McGee J., et al. Clostridium difficile colitis associated with infant botulism: Near-fatal case analogous to Hirschsprung's enterocolitis. Clin Infect Dis. 1999; 29 (2): 367-374.
45. L'Hommedieu C., Stough R., Brown L., et al. Potentiation of neuromuscular weakness in infant botulism by aminoglycosides. J Pediatr. 1979; 95 (6): 1065-1070.
46. Glauser TA, Maguire HC, Sladky JT Relapse of infant botulism. Ann Neurol. 1990; 28 (2): 187-189.
47. L'Hommedieu C., Polin RA Progression of clinical signs in severe infant botulism. Therapeutic implications. Clin Pediatr (Phila). 1981; 20 (2): 90-95.